Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWHydroquinine is a cinchona alkaloid that has been found in Cinchona bark and has diverse biological activities.1,2,3,4 It is active against clinical isolates of multidrug-resistant P. aeruginosa (MICs = 2.5 mg/ml for all) and P. knowlesi.2,3 Hydroquinine inhibits potassium currents in Xenopus oocytes expressing the human sodium-activated potassium channel KNa1.1 (IC50 = 93.9 µM) in an inside-out patch-clamp assay and decreases seizure severity in a mouse model of spontaneous epilepsy induced by mutant KCNT1, the gene encoding KNa1.1.4 It has been used as a building block in the synthesis of polymers for the delivery of plasmid DNA in vitro.5 Formulations containing hydroquinine have been used in the treatment of muscle cramps.
WARNING This product is not for human or veterinary use.
1. Quantitative determination of major alaloids in Cinchona bark by supercritical fluid chromatography. J. Chromatogr. A 1554, 117-122 (2018).
2. Hydroquinine inhibits the growth of multidrug-
3. Chloroquine and dihydroquinine. In vitro studies of their antimalarial effect upon Plasmodium knowlesi. J. Pharmacol. Exp. Ther. 164(2), 380-386 (1968).
4. Electrophysiological characterization of human KCNT1 channel modulators and the therapeutic potential of hydroquinine and tipepidine in KCNT1 mutation-
5. Enhancing pDNA delivery with hydroquinine polymers by modulating structure and composition. JACS Au. 3(7), 1876-1889 (2023).